ABVC BioPharma (ABVC) Institutional Ownership → No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free (From Hedgeye) (Ad) Free ABVC Stock Alerts $0.78 -0.01 (-1.52%) (As of 06/7/2024 08:51 PM ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for ABVC BioPharma (NASDAQ:ABVC)CurrentInstitutional OwnershipPercentage11.38%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$233.67KNumber ofInstitutional Sellers(last 12 months)0 Get ABVC Insider Trade Alerts Want to know when executives and insiders are buying or selling ABVC BioPharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad Paradigm PressElon Musk’s Final Masterpiece: “X-9840”The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840. Click here to see the details because there’s not much time to prepare. ABVC BioPharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/2/2024 Chase Investment Counsel Corp178,377$233K0.1%N/A1.689% 11/16/2021 Squarepoint Ops LLC19,207$44K0.0%N/A0.072% 11/12/2021 Credit Suisse AG11,709$27K0.0%N/A0.044% (Data available from 1/1/2016 forward) ABVC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ABVC shares? During the previous two years, the following institutional investors and hedge funds held shares of ABVC BioPharma shares: Chase Investment Counsel Corp ($233K).Learn more on ABVC's institutional investors. What percentage of ABVC BioPharma stock is owned by institutional investors? 11.38% of ABVC BioPharma stock is owned by institutional investors. Learn more on ABVC's institutional investor holdings. Which institutional investors have been buying ABVC BioPharma stock? The following institutional investors have purchased ABVC BioPharma stock in the last 24 months: Chase Investment Counsel Corp ($178.38K). How much institutional buying is happening at ABVC BioPharma? Institutional investors have bought a total of 178,377 shares in the last 24 months. This purchase volume represents approximately $233.67K in transactions. Related Companies: Marker Therapeutics Institutional Ownership ProMIS Neurosciences Institutional Ownership Equillium Institutional Ownership BioVie Institutional Ownership Spruce Biosciences Institutional Ownership Unicycive Therapeutics Institutional Ownership Bolt Biotherapeutics Institutional Ownership ImmunoPrecise Antibodies Institutional Ownership Unity Biotechnology Institutional Ownership BriaCell Therapeutics Institutional Ownership This page (NASDAQ:ABVC) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredYou won't believe what Citigroup just did to it's depositorsThe FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st...American Alternative | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ABVC BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ABVC BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.